Method for treatment of copd and other pulmonary diseases

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/12 (2006.01) A61K 31/522 (2006.01) A61K 31/56 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2740360

A method for treatment of patients with pulmonary diseases by providing an aerosolized combination of a methylxanthine and a topical steroid administered into a patient's conducting and central airways. The method utilizes a specific treatment protocol and a nebulizing system providing an aerosol having particles of a predetermined mass medial aerodynamic diameter (MMAD) delivered to the conducting and central lungs with overpressure and under controlled conditions.

Linvention concerne une méthode de traitement de patients atteints de maladies pulmonaires par mise à disposition dune combinaison aérosolisée dune méthylxanthine et dun stéroïde topique administrée dans les voies conductrices et centrales dun patient. La méthode utilise un protocole de traitement spécifique et un système de nébulisation qui fournit un aérosol ayant des particules dun diamètre aérodynamique médian en masse (MMAD) prédéterminé, qui est délivré aux poumons conducteurs et centraux avec une surpression et en conditions contrôlées.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for treatment of copd and other pulmonary diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of copd and other pulmonary diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of copd and other pulmonary diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1665404

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.